Abstract
The current production of recombinant insulin via fermenter-based platforms (Escherichia coli and yeast) could not fulfill its fast-growing commercial demands, thus leading to a great interest in its sustainable large-scale production at low cost using a plant-based system. In the present study, Agrobacterium tumefaciens-mediated nuclear stable genetic transformation of an industrial oilseed crop, Camelina sativa, to express pro-insulin (with three furin endoprotease cleavage sites) fused with cholera toxin B subunit (CTB) in their seeds was successfully achieved for the first time. The bar gene was used as a selectable marker for selecting transformants and producing herbicide-resistant camelina plants. The transformation process involved the infiltration of camelina inflorescences (at flower buds with partially opened flowers) with A. tumefaciens and harvesting the seeds (T0) at maturity. The T0 seeds were raised into the putative T1 plants sprayed with Basta herbicide (0.03%, v/v), and the survived green transformed plants tested positive for pro-insulin and bar genes. A transformation frequency of 6.96% was obtained. The integration and copy number of the pro-insulin transgene and its expression at RNA and protein levels were confirmed in T1 plants using Southern hybridization, semi-quantitative Reverse Transcriptase-Polymerase Chain Reaction (sqPCR), and quantitative real-time Time PCR (qPCR) and western blot analysis, respectively. Enzyme-linked immunosorbent Assay (ELISA) quantified the amount of expressed pro-insulin protein, and its anti-diabetic efficacy was validated in diabetic rats on oral feeding. Transgenic plants integrated the pro-insulin gene into their genomes and produced a maximum of 197 µg/100 mg of pro-insulin (0.804% of TSP) that had anti-diabetic efficacy in rats.
Similar content being viewed by others
Data Availability
The data obtained or analyzed in the present study have been incorporated in this manuscript.
References
WHO. (2021). Diabetes: World Health Organization, 11 November 2021. https://www.who.int› Health topics
WHO. (2022). Diabetes: World Health Organization 24 November 2022 https://www.who.int/health-topics/diabetes#tab=tab_1
Basu, S., Yudkin, J. S., Kehlenbrink, S., Davies, J. I., Wild, S. H., Lipska, K. J., Sussman, J. B., & Beran, D. (2019). Estimation of global insulin use for type 2 diabetes, 2018–30: A microsimulation analysis. The Lancet Diabetes Endocrinology, 7, 25–33. https://doi.org/10.1016/S2213-8587(18)30303-6
Bhoria, S., Yadav, J., Yadav, H., Chaudhary, D., Jaiwal, R., & Jaiwal, P. K. (2022). Current advances and future prospects in producing recombinant insulin and other proteins to treat diabetes mellitus. Biotechnology Letters, 44, 643–669. https://doi.org/10.1007/s10529-022-03247-w
Boyhan, D., & Daniell, H. (2011). Low-cost production of proinsulin in tobacco and lettuce chloroplasts for injectable or oral delivery of functional insulin and C-peptide. Plant Biotechnology Journal, 9, 585–598. https://doi.org/10.1111/j.1467-7652.2010.00582.x
Sims, E. K., Carr, A. L. J., Oram, R. A., DiMeglio, L. A., & Evans-Molina, C. (2021). 100 years of insulin: Celebrating the past, present and future of diabetes therapy. Nature Medicine, 27, 1154–1164. https://doi.org/10.1038/s41591-021-01418-2
Ferrer-Miralles, N., Domingo-Espin, J., Corchero, J. L., Vázquez, E., & Villaverde, A. (2009). Microbial factories for recombinant pharmaceuticals. Microbial Cell Factory, 8, 17. https://doi.org/10.1186/1475-2859-8-17
Siew, Y. Y., & Zhang, W. (2021). Downstream processing of recombinant human insulin and its analogs production from E. coli inclusion bodies. Bioresource Bioprocess, 8, 65. https://doi.org/10.1186/s40643-021-00419-w
Khan, I., & Daniell, H. (2021). Oral delivery of therapeutic proteins bioencapsulated in plant cells: Preclinical and clinical advances. Current Opinion Colloid Interface Science, 54, 101452. https://doi.org/10.1016/j.cocis.2021.101452
Sainger, M., Jaiwal, A., Sainger, P. A., Chaudhary, D., Jaiwal, R., & Jaiwal, P. K. (2017). Advances in genetic improvement of Camelina sativa for biofuel and industrial bioproducts. Renewable Sustainable Energy Reviews, 68, 623–637. https://doi.org/10.1016/j.rser.2016.10.023
Singh, R., Nasim, M., & Tiwari, S. (2014). Camelina sativa: Success of a temperate biofuel crop as intercrop in tropical conditions of Mhow, Madhya Pradesh, India. Current Science, 107, 359–360.
Mondor, M., & Hernández-Álvarez, A. J. (2021). Camelina sativa: Composition, attributes, and applications: A review. European Journal Lipid Science Technology. https://doi.org/10.1002/ejlt.202100035
Yuan, L., & Li, R. (2020). Metabolic engineering a model oilseed Camelina sativa for the sustainable production of high-value designed oils. Frontiers Plant Science, 11, 11. https://doi.org/10.3389/fpls.2020.00
Lu, C., & Kang, J. (2008). Generation of transgenic plants of a potential oilseed crop Camelina sativa by Agrobacterium-mediated transformation. Plant Cell Reports, 27, 273–278. https://doi.org/10.1007/s00299-007-0454-0
Liu, X., Brost, J., Hutcheon, C., Guilfoil, R., Wilson, A., Leung, S., Shewmaker, C. K., Rooke, S., Nguyen, T., Kiser, J., & De Rocher, J. (2012). Transformation of the oilseed crop Camelina sativa by Agrobacterium-mediated floral dip and simple large-scale screening of transformants. In Vitro Cellular Development Biology- Plant, 48, 462–468. https://doi.org/10.1007/s11627-012-9459-7
Herman, E. M., & Schmidt, M. A. (2010). Industrial protein production crops: New needs and new opportunities. GM Crops, 1, 2–7. https://doi.org/10.4161/gmcr.1.1.10671
Xia, Y. H., Wang, H. L., Ding, B. J., Svensson, G. P., Jarl-Sunesson, C., Cahoon, E. B., Hofvander, P., & Löfstedt, C. (2021). Green chemistry production of codlemone, the sex pheromone of the codling moth (Cydia pomonella), by metabolic engineering of the oilseed crop camelina (Camelina sativa). Journal Chemical Ecology, 47, 950–967. https://doi.org/10.1007/s10886-021-01316-4
Froger, A., & Hall, J. E. (2007). Transformation of plasmid DNA into E. coli using the heat shock method. Journal Visualized Experiments. https://doi.org/10.3791/253
Yadav, H., Malik, K., Parmar, S., Kumar, S., & Jaiwal, P. K. (2021). Generation of polyclonal antibodies against recombinant Agrobacterium tumefaciens decaprenyl diphosphate synthase produced in Escherichia coli. Journal Plant Biochemistry Biotechnology, 30, 487–495. https://doi.org/10.1007/s13562-020-00635-z
Jyothishwaran, G., Kotresha, D., Selvaraj, T., Srideshikan, S. M., Rajvanshi, P. K., & Jayabaskaran, C. (2007). A modified freeze–thaw method for efficient transformation of Agrobacterium tumefaciens. Current Science, 93, 770–772.
Rogers, S. O., & Bendich, A. J. (1989). Extraction of DNA from plant tissues. In S. B. Gelvin, R. A. Schilperoort, & D. P. S. Verma (Eds.), Plant molecular biology manual (pp. 73–83). Springer.
Nanda, J., Mani, M., Mishra, S. B., & Verma, N. (2023). Antihyperglycemic activity of Plumeria alba Linn leaves extracts in streptozotocin-nicotinamide induced diabetic rats. Biomedical Pharmacology Journal, 16, 567–571.
Clough, S. J., & Bent, A. F. (1998). Floral dip: A simplified method for Agrobacterium-mediated transformation of Arabidopsis thaliana. Plant Journal, 16, 735–743. https://doi.org/10.1046/j.1365-313x.1998.00343.x
Qing, C. M., Fan, L., Lei, Y., Bouchez, D., Tourneur, C., Yan, L., & Robaglia, C. (2000). Transformation of Pakchoi (Brassica rapa L. ssp. chinensis) by Agrobacterium infiltration. Molecular Breeding, 6, 67–72. https://doi.org/10.1023/A:1009658128964
Curtis, I. S., & Nam, H. G. (2001). Transgenic radish (Raphanus sativus L. longipinnatus Bailey) by floral-dip method-plant development and surfactant are important in optimizing transformation efficiency. Transgenic Research, 10, 363–371. https://doi.org/10.1023/A:1016600517293
Wang, W. C., Menon, G., & Hansen, G. (2003). Development of a novel Agrobacterium-mediated transformation method to recover transgenic Brassica napus plants. Plant Cell Reports, 22, 274–281.
Chhikara, S., Chaudhary, D., Yadav, M., Sainger, M., & Jaiwal, P. K. (2012). A non-tissue culture approach for developing transgenic Brassica juncea L. plants with Agrobacterium tumefaciens. In Vitro Cellular Development Biology-Plant, 48, 7–14. https://doi.org/10.1007/s11627-011-9408-x
Chen, G., Zeng, F., Wang, J., Ye, X., Zhu, S., Yuan, L., Hou, J., & Wang, C. (2019). Transgenic Wucai (Brassica campestris L.) produced via Agrobacterium-mediated anther transformation in planta. Plant Cell Reports, 38, 577–586. https://doi.org/10.1007/s00299-019-02387-0
Kumar, A., Sainger, M., Jaiwal, R., Chaudhary, D., & Jaiwal, P. K. (2021). Tissue culture- and selection-independent Agrobacterium tumefaciens-mediated transformation of a recalcitrant grain legume, Cowpea (Vigna unguiculata L. Walp). Molecular Biotechnology, 63, 710–718. https://doi.org/10.1007/s12033-021-00333-8
Chen, X., Lai, S., Zhuang, C., Huang, J., & Hu, Y. (2022). Sandwich Ct real-time PCR identifies single-copy T-DNA integration accumulating in backbone-free transgenic T1 Arabidopsis. Plant Science, 318, 111204. https://doi.org/10.1016/j.plantsci.2022.111204
Berti, M., Samarappuli, D., Johnson, B. L., & Gesch, R. W. (2017). Integrating winter camelina into maize and soybean cropping systems. Industrial Crops Production, 107, 595–601.
Yemets, A. I., Boychuk, Y. N., Shysha, E. N., Rakhmetov, D. B., & Blume, Y. B. (2013). Establishment of in vitro culture, plant regeneration, and genetic transformation of Camelina sativa. Cytology Genetics, 47, 138–144. https://doi.org/10.3103/S0095452713030031
Ontiveros-Cisneros, A., Moss, O., Van Moerkercke, A., & Van Aken, O. (2022). Evaluating antibiotic-based selection methods for Camelina sativa stable transformants. Cells, 11, 1068. https://doi.org/10.3390/cells11071068
Sitther, V., Tabatabai, B., Enitan, O., & Dhekney, S. (2018). Agrobacterium-mediated transformation of Camelina sativa for production of transgenic plants. Journal Biological Methods, 5, e83. https://doi.org/10.14440/jbm.2018.208
Kang, J., Snapp, A. R., & Lu, C. (2011). Identification of three genes encoding microsomal oleate desaturases (FAD2) from the oilseed crop Camelina sativa. Plant Physiology Biochemistry, 49, 223–229. https://doi.org/10.1016/j.plaphy.2010.12.004
Walsh, K. D., Puttick, D. M., Hills, M. J., Yang, R. C., Topinka, K. C., & Hall, L. M. (2012). First report of outcrossing rates in camelina (Camelina sativa (L.) Crantz), a potential platform for bioindustrial oils. Canadian Journal Plant Science, 92, 681–685. https://doi.org/10.4141/cjps2011-182
Bansal, S., Kim, H. J., Na, G., Hamilton, M. E., Cahoon, E. B., Lu, C., & Durrett, T. P. (2018). Towards the synthetic design of camelina oil enriched in tailored acetyl-triacylglycerols with medium-chain fatty acids. Journal Experimental Botany, 69, 4395–4402. https://doi.org/10.1093/jxb/ery225
Šutá, D., Matušíková, I., & Blehová, A. (2019). Targeting transgene to seed resulted in a high rate of morphological abnormalities of Camelina transformants. Nova Biotechnologia Chimica, 18, 94–101. https://doi.org/10.2478/nbec-2019-0012
Boothe, J., Nykiforuk, C., Shen, Y., Zaplachinski, S., Szarka, S., Kuhlman, P., Murray, E., Morck, D., & Moloney, M. M. (2010). Seed-based expression systems for plant molecular farming. Plant Biotechnology Journal, 8, 588–606. https://doi.org/10.1111/j.1467-7652.2010.00511.x
Wahren, J., Ekberg, K., & Jörnvall, H. (2007). C-peptide is a bioactive peptide. Diabetologia, 50, 503–509. https://doi.org/10.1007/s00125-006-0559-y
Hörber, S., Achenbach, P., Schleicher, E., & Peter, A. (2020). Harmonization of immunoassays for biomarkers in diabetes mellitus. Biotechnology Advances, 39, 107359. https://doi.org/10.1016/j.biotechadv.2019.02.015
Nykiforuk, C. L., Boothe, J. G., Murray, E. W., Keon, R. G., Joseph Goren, H., Markley, N. A., & Moloney, M. M. (2006). Transgenic expression and recovery of biologically active recombinant human insulin from Arabidopsis thaliana seeds. Plant Biotechnology Journal, 4, 77–85.
Chen, Y. S., Zaro, J. L., Zhang, D., Huang, N., Simon, A., & Shen, W. C. (2018). Characterization and oral delivery of proinsulin-transferrin fusion protein expressed using express-Tec. International Journal Molecular Science, 19, 378. https://doi.org/10.3390/ijms19020378
Daniell, H., Nair, S. K., Guan, H., Guo, Y., Kulchar, R. J., Torres, M. D., Shahed-Al-Mahmud, M., Wakade, G., Liu, Y. M., Marques, A. D., & Graham-Wooten, J. (2022). Debulking different Corona (SARS-COV-2 delta, omicron, OC43) and influenza (H1N1, H3N2) virus strains by plant viral trap proteins in chewing gums to decrease infection and transmission. Biomaterials, 288, 121671. https://doi.org/10.1016/j.biomaterials.2022.121671
Acknowledgements
PKJ and SB are thankful to the University Grants Commission, New Delhi, for the award of the Basic Science Research-Faculty Fellowship and Senior Research Fellowship, respectively and to Prof. Edgar Cahoon, University of Nebraska-Lincoln, USA for pBinGy1bar. No special funding for this work was available.
Funding
No special funding was available for this work.
Author information
Authors and Affiliations
Contributions
SB contributed toward methodology, investigation, analysis, and writing-original draft. PS contributed toward interpretation of data. DC contributed toward project administration, resources, writing review, and editing. RJ contributed toward conceptualization, study design, writing review, and editing. PKJ contributed toward conceptualization, supervision, writing review, and editing.
Corresponding author
Ethics declarations
Conflict of interests
The authors do not have a conflict of interest.
Ethical Approval
The use of small animals in the present study was approved by the Institutional Animal Ethical Committee (IAEC) of CPCSEA (Committee for the Purpose of Control and Supervision of Experiments on Animals), M. D. University, Rohtak-124001(India).
Consent for Publication
All co-authors have given their consent for publication.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Bhoria, S., Saini, P., Chaudhary, D. et al. Engineering Camelina sativa Seeds as a Green Bioreactor for the Production of Affordable Human Pro-insulin that Demonstrates Anti-diabetic Efficacy in Rats. Mol Biotechnol (2024). https://doi.org/10.1007/s12033-024-01068-y
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12033-024-01068-y